These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 7988782)

  • 1. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.
    Mitrakou A; Ryan C; Veneman T; Mokan M; Jenssen T; Kiss I; Durrant J; Cryer P; Gerich J
    Am J Physiol; 1991 Jan; 260(1 Pt 1):E67-74. PubMed ID: 1987794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia.
    Snorgaard O; Lassen LH; Rosenfalck AM; Binder C
    J Intern Med; 1991 Apr; 229(4):343-50. PubMed ID: 2026987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
    Sjöberg S; Ahrén B; Bolinder J
    J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
    Banarer S; McGregor VP; Cryer PE
    Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.
    Aitken ML; Szkudlinska MA; Boyko EJ; Ng D; Utzschneider KM; Kahn SE
    Diabetologia; 2020 May; 63(5):1055-1065. PubMed ID: 31993716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic and counterregulatory hormonal responses to acute hypoglycaemia induced by insulin aspart and soluble human insulin in Type 1 diabetes.
    Frier BM; Ewing FM; Lindholm A; Hylleberg B; Kanc K
    Diabetes Metab Res Rev; 2000; 16(4):262-8. PubMed ID: 10934454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects.
    Vea H; Jorde R; Sager G; Vaaler S; Sundsfjord J
    Diabetologia; 1992 Oct; 35(10):958-61. PubMed ID: 1451953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Di Vincenzo A; Modarelli F; Ciofetta M; Lepore M; Annibale B; Torlone E
    Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulatory hormone and symptom responses to hypoglycaemia in diabetic children.
    Bjørgaas M; Vik T; Sand T; Birkeland K; Sager G; Vea H; Jorde R
    Diabet Med; 1997 Jun; 14(6):433-41. PubMed ID: 9212307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
    Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
    Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state.
    Fanelli CG; Pampanelli S; Porcellati F; Bartocci L; Scionti L; Rossetti P; Bolli GB
    Diabetologia; 2003 Jan; 46(1):53-64. PubMed ID: 12637983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
    Verhulst CEM; Fabricius TW; Teerenstra S; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pedersen-Bjergaard U; de Galan BE;
    Diabetologia; 2022 Oct; 65(10):1601-1612. PubMed ID: 35867127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans.
    Mellman MJ; Davis MR; Brisman M; Shamoon H
    Diabetes Care; 1994 Mar; 17(3):183-8. PubMed ID: 8174445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the glucagon response to hypoglycaemia in patients with type 1 diabetes and in healthy subjects.
    Liu D; Adamson U; Lins PE; Clausen-Sjöbom N
    Diabet Med; 1993 Apr; 10(3):246-54. PubMed ID: 8485956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.
    Rossetti P; Porcellati F; Busciantella Ricci N; Candeloro P; Cioli P; Nair KS; Santeusanio F; Bolli GB; Fanelli CG
    Diabetes; 2008 Jul; 57(7):1905-17. PubMed ID: 18390791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.